INT42994
From wiki-pain
|
|
|
|
|
Sentences Mentioned In
Key: | Protein | Mutation | Event | Anatomy | Negation | Speculation | Pain term | Disease term |
Anti-Ro is associated closely with a photosensitive rash and with subacute lupus. | |||||||||||||||
| |||||||||||||||
|
Anti-HCV status was independently associated with duration of drug use of over 10 years, injecting as a route of drug administration, and hepatitis B virus (HBV) and human immunodeficiency virus (HIV) seropositivity. | |||||||||||||||
| |||||||||||||||
|
In our cohort we did not find a substantial association between anti-MCV levels and disease activity. | |||||||||||||||
| |||||||||||||||
|
The present study focuses on the association between anti-MCV levels and DAS28 in patients with early arthritis over 2 years of follow up. | |||||||||||||||
| |||||||||||||||
|
GEE analysis revealed a significant association between DAS28 and anti-MCV during 2 years of follow up, although the association was very low. | |||||||||||||||
| |||||||||||||||
|
Two other anti-LAM1 antibodies, anti-LAM1-3 and anti-LAM1-5 stay antigen-bound at the same time. | |||||||||||||||
| |||||||||||||||
|
Brief treatment of human peripheral blood lymphocytes with the potential anti-HIV compound aurintricarboxylic acid (ATA) prompts the selective release of already bound L-selectin-specific anti-Leu8 and anti-LAM1-1 antibodies from the cells. | |||||||||||||||
| |||||||||||||||
|
The peptides are produced after stimulation with the mitogenic monoclonal antibodies anti-CD2.1/2.2 and anti-CD28. | |||||||||||||||
| |||||||||||||||
|
In an in vitro assay system, immobilized epratuzumab crosslinked with anti-IgG had different effects, depending on the cell type studied. | |||||||||||||||
| |||||||||||||||
|
Immunoglobulin G anti-dsDNA autoantibodies were associated with positivity for ANA, and remained positive until the end of the study, including three of four positive patients who discontinued the treatment. | |||||||||||||||
| |||||||||||||||
|
Factors independently associated with positive anti-HBc were IVDA, foreign country of birth, non-white ethnicity and high age. | |||||||||||||||
| |||||||||||||||
|
Factors independently associated with positive anti-HBc were intravenous drug abuse (OR 18.3; 11.3 to 29.7), foreign country of birth (3.4; 2.6 to 4.4), non-white ethnicity (2.7; 1.9 to 3.8) and age ? | |||||||||||||||
| |||||||||||||||
|
The prerequisite for binding of anti-DNA antibodies is the recognition of either a phosphosugar backbone of dsDNA (for anti dsDNA autoantibodies) or a thymidine pentamer in ssDNA (for antiss-DNA autoantibodies) while the prerequisite for hydrolysis is binding itself. | |||||||||||||||
| |||||||||||||||
|
Most of the authors used DNA-cellulose purification based upon the technique pioneered by Moss et al. [3] wherein the DNA bound either anti-ssDNA or anti-dsDNA or both directly from sera. | |||||||||||||||
| |||||||||||||||
|
Tanner et al. in 2001 illustrated the specific binding of anti-DNA antibodies to thymidine polymers via arginine groups using X-ray analysis. | |||||||||||||||
| |||||||||||||||
|
To our knowledge, our lab was the first to develop a specific and simple method for isolating and purifying human anti-DNA (IgG) antibodies from the SLE patients' serum, based on the specific binding of anti-DNA antibodies to thymine polymers (anti-DNA antibody base specificity is dT ? | |||||||||||||||
| |||||||||||||||
|
The methods created and applied in the past were mainly done to detect the anti-DNA structural and functional characteristics (e.g., substrate binding, hydrolytic, and cytotoxic activity). | |||||||||||||||
| |||||||||||||||
|
A greater proportion of anti-dsDNA IgG-binding antibodies purified from patients with active lupus nephritis binds to ? | |||||||||||||||
| |||||||||||||||
|
At multivariate analysis, a combination of anti-C1q, C3, and C4 provided the best performance for predicting renal flares. | |||||||||||||||
| |||||||||||||||
|
Since platelet aggregation has been demonstrated to be mediated exclusively by the binding of plasma fibrinogen to the activated GP IIb/IIIa, anti-GP IIb/IIIa agents, which can completely inhibit platelet aggregation, were expected to become among the most potent of antithrombotic agents. | |||||||||||||||
| |||||||||||||||
|
General Comments
This test has worked.